LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

MIC Capital Management UK LLP's Holding History (CIK: 0001889830)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,740,569 Value ($000) $936 Avg Close — Range —
Q4 2024
Shares 1,740,569 Value ($000) $1,114 Avg Close — Range —
Q3 2024
Shares 1,740,569 Value ($000) $2,402 Avg Close — Range —
Q2 2024
Shares 1,740,569 Value ($000) $2,524 Avg Close — Range —
Q1 2024
Shares 1,740,569 Value ($000) $3,881 Avg Close — Range —
Q4 2023
Shares 1,740,569 Value ($000) $3,377 Avg Close — Range —
Q3 2023
Shares 1,740,569 Value ($000) $2,559 Avg Close — Range —
Q2 2023
Shares 3,060,569 Value ($000) $9,733 Avg Close — Range —
Q1 2023
Shares 3,060,569 Value ($000) $7,223 Avg Close — Range —
Q4 2022
Shares 3,060,569 Value ($000) $10,620 Avg Close — Range —
Q3 2022
Shares 3,060,569 Value ($000) $22,434 Avg Close — Range —
Q2 2022
Shares 3,060,569 Value ($000) $19,955 Avg Close — Range —
Q1 2022
Shares 1,320,000 Value ($000) $6,666 Avg Close — Range —
Q4 2021
Shares 1,320,000 Value ($000) $10,217 Avg Close — Range —